QA: Diadexus Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001036968_2013_Diadexus_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'0120 - Statement - Statements of Comprehensive Loss': 15, '0121 - Statement - Statements of Comprehensive Loss (Alternative)': 2}}

Graph

Absolute values for 0001036968, Diadexus Inc

  xvar xval
0 AssetsCurrent 17,692,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,250,000
3 remainder_Assets 1,542,000
4 LiabilitiesCurrent 3,599,000
5 LiabilitiesNoncurrent 346,000
6 remainder_Liabilities 7,684,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,217,000
9 ResearchAndDevelopmentExpense 4,196,000
10 remainder_Expenses 12,158,000
11 remainder_Revenues 20,776,000
12 remainder_NetIncome 6,000
13 remainder_ComprehensiveNetIncome 5,000
  yvar yval
0 Assets 20,484,000
1 Liabilities 11,629,000
2 Expenses 23,571,000
3 Revenues 20,776,000
4 StockholdersEquity 8,855,000
5 NetIncome -2,789,000
6 ComprehensiveNetIncome -2,786,500
7 BaseVar 38,235,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.03
9 EconomicCapitalRatio 2.32

Edgar->Model Mapping

Feature Distribution

Change over Time